Colloids dispersed in liquid crystals (LCs) diffuse preferentially along the LC director because this direction of displacement generates the lowest hydrodynamic drag. In this article, we report on the active transport of micrometer-sized nematic droplets of 4'-pentyl-4-biphenylcarbonitrile (5CB) propelled through a continuous LC phase formed from aqueous solutions of disodium cromoglycate (DSCG) by Marangoni stresses (generated through the addition of sodium dodecyl sulfate (SDS)). We observe the nematic droplets to exhibit motion guided by the continuous LC phase, but in contrast to passive diffusion, the LC droplets move preferentially in a direction perpendicular to the continuous-phase LC director. Our results suggest that the LC droplets, with internal symmetry broken by the Marangoni flow, interact through orientation-dependent van der Waals forces with the LC continuous phase, biasing the orientation of the droplets and the direction of propulsion orthogonal to the far-field director of the continuous LC phase. This proposal is supported by measurements of the orientations of droplets of 5CB and 4-ethoxy-4'-(6-acryloyloxyhexyloxy) azobenzene (RM257) polymerized in a preradial director configuration, which reveal the polymerized droplets to adopt orientations that are biased toward the perpendicular of the far-field DSCG director. Additionally, we demonstrate that preferential motion parallel to the continuous-phase LC director is recovered when using self-propelled isotropic oil droplets. We also observe periodic changes in the instantaneous velocities of LC droplets. We show the changes to correlate with the formation and detachment of satellite droplets, consistent with the solubilization of the nematic oil into surfactant assemblies near the trailing edge of the droplets and their accumulation near a stagnation region downstream of the droplet. Overall, our results provide fundamental insights into ways in which LC ordering can change the dynamics of active colloidal systems and hint at principles by which the motion of active colloids can be steered.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.langmuir.9b02975 | DOI Listing |
Sci Data
January 2025
Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
As the occurrence of human diseases and conditions increase, questions continue to arise about their linkages to chemical exposure, especially for per-and polyfluoroalkyl substances (PFAS). Currently, many chemicals of concern have limited experimental information available for their use in analytical assessments. Here, we aim to increase this knowledge by providing the scientific community with multidimensional characteristics for 175 PFAS and their resulting 281 ion types.
View Article and Find Full Text PDFBMJ Open Qual
January 2025
Professor Department of Obstetrics and Gynaecology, Lady Hardinge Medical College, New Delhi, India.
Background: Allowing a birth companion is the basic right of a mother and is identified as an important component of respectful maternity care. The implementation of this intervention has been a challenge in heavy-load public health facilities in India.
Local Problem: Despite the proven benefits of the presence of birth companions on maternal-fetal outcomes, there was no policy of allowing birth companions in our hospital.
Bioresour Technol
January 2025
University of Zagreb Faculty of Chemical Engineering and Technology, Marulićev trg 19, HR-10000 Zagreb, Croatia. Electronic address:
Efforts to reduce the impact of chemical processes on the environment are leading to a shift to enzymatic alternatives, with laccases standing out for their versatile substrate oxidation capabilities. This study addresses the improvement of biocatalytic reactions by deep eutectic solvents (DES), in particular DES-based aqueous two-phase systems (ATPS) for the extraction of biomolecules. Continuous laccase extraction from crude samples was achieved using a DES-based ATPS, which was first optimized in a batch extractor and later intensified in a microextractor.
View Article and Find Full Text PDFLancet Neurol
February 2025
Janssen Research & Development, a Johnson & Johnson Company, Titusville, NJ, USA.
Background: Given burdensome side-effects and long latency for efficacy with conventional agents, there is a continued need for generalised myasthenia gravis treatments that are safe and provide consistently sustained, long-term disease control. Nipocalimab, a neonatal Fc receptor blocker, was associated with dose-dependent reductions in total IgG and anti-acetylcholine receptor (AChR) antibodies and clinically meaningful improvements in the Myasthenia Gravis Activities of Daily Living (MG-ADL) scale in patients with generalised myasthenia gravis in a phase 2 study. We aimed to assess the safety and efficacy of nipocalimab in a phase 3 study.
View Article and Find Full Text PDFBr J Dermatol
January 2025
Department of Dermatology, Yale University, New Haven, Connecticut, USA.
Background: Overexpression of interleukin (IL)-17A and IL-17F significantly influences psoriasis pathology. Until recently, biologics targeting IL-17A alone, like secukinumab, were used to treat psoriasis. Bimekizumab is a monoclonal IgG1 antibody that targets both IL-17A and IL-17F.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!